C4 Therapeutics
Katherine Parmington is a Senior Director at C4 Therapeutics, Inc., bringing with their a wealth of experience in accounting operations. Prior to their current role, Katherine held various positions at Rubius Therapeutics, including Associate Director, Assistant Controller, Senior Manager, and Manager in the accounting department. Katherine also has a background in auditing from their time at Deloitte, where Katherine started as an Audit Assistant and worked their way up to an Audit Senior position. Katherine began their career as an Accountant at Etex Corporation after completing their Bachelor's degree in Financial Economics at the University of Rochester. Katherine holds a Master of Science in Accounting and an MBA from the D'Amore-McKim School of Business at Northeastern University.
C4 Therapeutics
6 followers
C4 Therapeutics (C4T) is a biopharmaceutical company focused on harnessing the body’s natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases.